Developing Products for Non-healing Chronic Wounds: Wound Care Collaborative Community (WCCC) and the FDA Perspectives

This session will address the following:
1. Outline current challenges in developing innovative products for non-healing chronic wounds.
2. Discuss the FDA’s collaborative role in wound care innovation
3. Discuss WCCC projects to address the identified challenges